Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

PercutaneOus StEm Cell Injection Delivery Effects On Neomyogenesis in Dilated CardioMyopathy (The POSEIDON-DCM Study) (PoseidonDCM)

This study is ongoing, but not recruiting participants.
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
Joshua M Hare, University of Miami Identifier:
First received: June 29, 2011
Last updated: October 21, 2016
Last verified: October 2016